News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Michael Chuong: The second special edition for SBRT/SRS in Cancers
Michael Chuong/mapquest.com
Feb 26, 2025, 11:44

Michael Chuong: The second special edition for SBRT/SRS in Cancers

Michael Chuong, Vice Chair, Medical Director, Dept of Radiation Oncology at Miami Cancer Institute, shared a post on LinkedIn:

“We are launching a 2nd special edition for SBRT/SRS in Cancers!

Manuscripts of interest are related to:

  • Novel SBRT/SRS clinical outcomes
  • Radiation dose escalation
  • Image guidance including MRI
  • Tumor motion management techniques
  • Dose constraints and toxicities
  • Novel treatment planning approaches
  • Artificial intelligence/machine learning

Deadline to submit is December 31, 2025.”

Read further.

More posts featuring Michael Chuong.

cancer cancers Michael Chuong OncoDaily Oncology SBRT SRS Stereotactic Ablative Radiotherapy Therapy Stereotactic Body Radiation
Special Coverage
Blog
Feb 26, 2025, 11:44
Michael Chuong: The second special edition for SBRT/SRS in Cancers
Science
Feb 26, 2025, 11:40
Jasmine Kamboj: Our patients are more than their cancer diagnoses
Blog
Feb 26, 2025, 11:15
Cristian Ochoa Arnedo: Vital Impact in the face of cancer
Science
Feb 26, 2025, 11:10
Bente Mikkelsen: How to Make the UN High-Level Meeting on NCDs Effective
Blog
Feb 26, 2025, 11:10
Andrea Necchi: A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment of RCC
Science
Feb 26, 2025, 11:05
Simrun Kaur-Rathore: The Role of 3D Printing and Augmented Reality in the Management of Hepatic Malignancies
Blog
Feb 26, 2025, 11:04
Mehezabin Dordi: Horizon - Looking Beyond Cancer with Strength
Blog
Feb 26, 2025, 10:59
Wafaa Rashed: Enhancing Public Awareness and Education of Genomic Research in Ghana
Science
Feb 26, 2025, 10:59
Elvina Almuradova: How GEMSTONE-303 differs from other trials
Oncolibrary
Feb 26, 2025, 10:54
New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience
Insight
Feb 26, 2025, 10:54
Pietro De Placido: The SURVIVE Study will challenge the "no symptoms, no scan" BC surveillance model
Insight
Feb 26, 2025, 10:50
Jarushka Naidoo: Mucinous lung adenocarcinomas - clinical features and outcomes